Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“The ganglionic blocker chlorisondamine , inhibits ACTH release during both phases of the response to ether by 40–60% when used alone, and by 100% when administered with anti-CRF antibody.”